Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

Business Wire • May 29, 2026

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

BlackRock Health Sciences Trust remains a steady income generator, never having cut its regular distribution since inception, despite recent lackluster results. BME's discount has narrowed, resulting in some outperformance relative to XLV on total share price return. I continue to hold BME for long-term income, viewing the current healthcare sector undervaluation as a potential opportunity for cautious, incremental additions.

Seeking Alpha • May 22, 2026

BME: Removal Of Option Writing Can Improve NAV Growth (Rating Upgrade)

BlackRock Health Sciences Trust is upgraded to a buy, benefiting from its shift to an equity-focused strategy and improved NAV growth prospects. BME offers an 8.3% monthly dividend yield, but coverage is inconsistent and reliant on net realized gains rather than stable investment income. Elimination of the option writing strategy positions BME to better capture upside in healthcare, especially with exposure to GLP-1 drug market leaders.

Seeking Alpha • Mar 29, 2026

5 ‘Healthy' Dividends Paying Up To 14.1%

Healthcare dividend stocks are selling off with the turbulence in the Middle East.

Forbes • Mar 22, 2026

7 Income-Oriented CEFs With Rising NAV And Distribution Increases For At Least 10+ Years

I highlight seven closed-end funds, or CEFs, with rising NAVs and increasing distributions over the past 10–15 years, spanning diverse asset classes. These CEFs—PEO, BDJ, BME, CSQ, UTF, STK, and GDV—offer strong total returns, resilient income growth, and trade at attractive discounts to NAV. Funds like STK and CSQ have outperformed the S&P 500 on a 10-year total return basis, while others like BME and UTF have never cut distributions.

Seeking Alpha • Mar 22, 2026

Never Cutters, Part 2: 5 More High-Yield CEFs That Have Never Cut The Distribution

I highlight five additional CEFs—BIT, BME, BST, BUI, and GLU—that have never cut distributions for at least a decade, offering high-yield, monthly income. BIT yields nearly 12% at a -6.8% discount, but declining earnings coverage and rising ROC signal caution on distribution sustainability. BME, BST, and BUI trade at discounts and have recently increased distributions, with BST delivering an 18% 10-year total return at market price.

Seeking Alpha • Mar 15, 2026

Closed-End Funds: My Top 10 Holdings February 2026

My closed-end fund portfolio update provides a more concentrated top 10, and that is on the back of a reduction in the number of holdings since last year. I remain leaning toward utility/infrastructure positioning, and that remains an attractive area of the market to generate predictable cash flows. In general, CEF discounts are fairly narrow compared to their historical levels, but the average discount has moved wider, at least slightly.

Seeking Alpha • Mar 6, 2026

Switching From THQ To BME Despite The Yield

The abrdn Healthcare Opportunities Fund has delivered strong historical returns but now faces sustainability concerns due to leverage, premium to NAV, and likely fee waiver expiration. THQ's 11% yield is increasingly funded by return of capital, with NAV erosion and potential distribution cuts on the horizon. BlackRock Health Sciences Trust offers a safer alternative: a 7.5% yield, a conservative distribution policy, no leverage, a lower expense ratio, and currently trades at a 5.6% discount to NAV.

Seeking Alpha • Jan 22, 2026

BME: Attractive Discount With Steady Monthly Distribution

BlackRock Health Sciences Trust has seen some strong performance recently, yet still trades at a -7.8% discount to NAV, offering compelling value. BME removed its options-writing strategy, eliminating upside caps and shifting focus to long-term capital appreciation in health sciences equities. Despite sector volatility and UNH headwinds, BME remains diversified in healthcare exposure, but some concentration in top holdings like LLY.

Seeking Alpha • Dec 29, 2025

The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners

Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.

Forbes • Dec 17, 2025